| Price | 62.50p on 08-01-2026 at 14:00:25 |
|---|---|
| Change | 0.90p 1.46% |
| Buy | 63.00p |
| Sell | 62.00p |
| Last Trade: | Buy 6,363.00 at 62.675p |
| Day's Volume: | 386,460 |
| Last Close: | 61.60p |
| Open: | 63.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 61.00p - 63.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £271.04m |
| VWAP: | 61.54961p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 6,363 | 62.675p | Ordinary |
13:53:00 - 08-Jan-26 |
| Buy* | 2,000 | 62.70p | Ordinary |
13:50:49 - 08-Jan-26 |
| Sell* | 415 | 61.2251p | Ordinary |
13:46:06 - 08-Jan-26 |
| Sell* | 111 | 61.2241p | Ordinary |
13:43:25 - 08-Jan-26 |
| Buy* | 20,000 | 63.00p | Ordinary |
13:39:56 - 08-Jan-26 |
| Sell* | 416 | 61.221p | Ordinary |
13:39:24 - 08-Jan-26 |
| Buy* | 1 | 63.00p | SI Trade |
13:34:39 - 08-Jan-26 |
| Buy* | 6,000 | 62.00p | Ordinary |
13:34:37 - 08-Jan-26 |
| Buy* | 7,350 | 61.83p | Ordinary |
13:33:47 - 08-Jan-26 |
| Buy* | 4,852 | 61.83p | Ordinary |
13:15:08 - 08-Jan-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Dec 2025 7:00 am | RNS-R | Avacta reports new AVA6103 pharmacology data |
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
